Scientists highlight some of the recent chemistry and preclinical advances in this space leading to this large number of clinical candidates against a diverse range of targets in liver hepatocytes.
[Molecular Therapy]
Bae, M., Lee, Y., Pham, T. X., Hu, S., Park, Y.-K., & Lee, J.-Y. (2020). Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells. Life Sciences, 256, 117926. https://doi.org/10.1016/j.lfs.2020.117926 Cite
0